CAMBRIDGE, Mass. — Origin Medical has named co-founder Sripad Krishna Devalla chief executive officer as the healthcare technology company prepares for the commercial launch of its AI-powered ultrasound workflow platform for prenatal care.
Devalla, who previously served as chief technology officer, succeeds co-founder Jens Thang as CEO. Thang will move into the role of chief operating officer, where he will lead commercial execution, operational scaling and market delivery as Origin Medical enters its next phase of growth.
The leadership transition is part of a broader expansion of the company’s executive team and board as Origin Medical shifts from product development toward commercialization.
“As we enter this next phase, our focus is on bringing AI into the core of prenatal care in a way that strengthens, not replaces, clinical expertise,” Devalla said. “We are building technology that fits naturally into the ultrasound workflow, helping clinicians manage day-to-day imaging with greater confidence while delivering consistent, high-quality care at scale.”
Devalla has overseen Origin Medical’s product strategy, platform architecture and artificial intelligence roadmap since the company’s founding. As CEO, he will focus on commercial growth, strategic partnerships and expansion in U.S. and international markets.
Thang, who has served as CEO since Origin Medical’s inception, said the leadership change reflects the company’s move into market execution.
“This is a pivotal moment for the company, and I am stepping into the COO role to lead the execution required for our next phase of growth,” Thang said. “We have built an exceptional platform, a highly capable team, and a strong foundation. My focus now is to convert that foundation into market-ready execution — scaling responsibly, operating with discipline, and delivering on our commitment to clinicians, patients, and partners.”
Origin Medical also announced several executive appointments to support clinical adoption, regulatory strategy, customer deployment and market expansion.
Jeroen P. Vanderhoeven has joined the company as chief medical officer and will oversee clinical strategy and regulatory alignment. Dawn Finlay Noahubi, RDMS, was named vice president of clinical affairs and applications, leading clinical programs and provider adoption initiatives. Allan Bottemiller joined as vice president of enterprise solutions, with responsibility for health system integration and customer success. Matt Brand was appointed vice president of marketing and will oversee go-to-market strategy and commercial alignment.
The company also added Chris Blackley, co-founder and CEO of Prescryptive Health, to its board of directors. Blackley has more than two decades of experience in healthcare technology, cloud platforms and health information policy.
As a board member, Blackley will advise Origin Medical on governance, enterprise commercialization, capital strategy and strategic relationships with health systems and payers.
Origin Medical said the leadership expansion comes as providers increasingly evaluate artificial intelligence tools to improve efficiency, workflow management and access to care. The company is positioning its platform as a way to support clinician decision-making and operational performance while addressing demand for prenatal imaging services.
The company’s next phase will focus on commercial growth and broader adoption of AI-enabled prenatal care technology.
